Cranberry als Phyto-Prophylaktikum bei bakteriellen Infektionen - Neue Forschungsergebnisse

Zusammenfassung

Neue Forschungsergebnisse zur Wirksamkeit der Cranberry (Vaccinium macrocarpon) als Prophylaktikum bei rezidivierenden Harnwegsinfekten, Helicobacter-pylori-Infektionen des oberen Gastrointestinaltrakts sowie bei Karies und parodontalen Erkrankungen werden vorgestellt. Proanthocyanidine der Cranberries hemmen die bakterielle Andockung an Gewebe in vitro. Auch nach oraler Aufnahme bleibt das Wirkprinzip im Urin von Probanden nachweisbar. Durch randomisierte klinische Studien ist die Prophylaxe von Harnwegsinfekten durch Cranberrysaft bei Frauen evidenzbasiert. Die hohe antioxidative Kapazität von Cranberryprodukten ist zusätzlich eindrucksvoll belegt.

Summary

The author presents new research findings on the efficacy of cranberry (Vaccinium macrocarpon) as a pharmaceutical agent in treating recurrent urinary tract infection, Helicobacter pylori infection of the upper gastrointestinal tract as well as caries and periodontal disease. In vitro, the proanthocyanidins in cranberries inhibit the docking of bacteria on tissues. The efficacy mechanism can be traced in the patient's urine following an oral intake of cranberry juice. As was shown in evidence based studies, cranberry juice leads to the prevention of urinary tract infection in women. The author also empirically verifies the high anti-oxidative capacity of cranberry products.

Schlüsselwörter

Cranberry - Vaccinium macrocarpon Aiton - Proanthocyanidine - Harnwegsinfekte - Escherichia coli - Helicobacter pylori - Karies - Parodontose - Antioxidans - Anti-Adhäsionswirkung

Key words

Cranberry - Vaccinium macrocarpon Aiton - Ericaceae - proanthocyanidins - urinary tract infection - Escherichia coli - Helicobacter pylori - caries - periodontal disease - antioxidant - anti-adhesive effect

Literatur

• 1 Nowack R. Die amerikanische Cranberry (Vaccinium macrocarpon Aiton) - Porträt einer Arzneipflanze.  Z Phytotherapie. 2003;  24 40-46
• 2 Säemann MD, Weichhart T. Ursachen der rezidivierenden Harnwegsinfektionen: neue Erkenntnisse.  Dtsch Med Wochenschr. 2005;  130 2031-2034
• 3 Arthur M, Johnson CE, Rubin RJ. et al. . Molecular epidemiology of adhesion and hemolysin virulence factors among uropathogenic Escherichia coli.  Infect Immun. 1989;  57 303-313
• 4 Rice JC, Peng T, Spence JS. et al. . Pyelonephritic Escherichia coli expressing P fimbriae decrease immune response of the mouse kidney.  J Am Soc Nephrol. 2005;  16 3583-3591
• 5 Sobota AE. Inhibition of bacterial adherence by cranberry juice: Potential use for the treatment of urinary tract infections.  J Urol. 1984;  131 1013-1016
• 6 Schmidt DR, Sobota AE. An examination of the anti-adherence activity of cranberry juice on urinary and nonurinary bacterial isolates.  Microbios. 1988;  55 173-181
• 7 Zafriri D, Ofek I, Adar R, Pocino M, Sharon N. Inhibitory activity of cranberry juice on adherence of type 1 and P fimbriated Escherichia coli to eucaryotic cells.  Antimicrob Agents Chemother. 1989;  33 92-98
• 8 Ofek I, Goldhar J, Zafriri D. et al. . Anti-Escherichia adhesin activity of cranberry and blueberry juices.  Adv Exp Med Biol. 1996;  408 179-183
• 9 Ofek I, Goldhar J, Zafriri D, Lis H, Adar R, Sharon N. Anti-Escherichia coli adhesin activity of cranberry and blueberry juices.  New Engl J Med. 1991;  324 1599
• 10 Howell AB, Vorsa N. et al. . Inhibition of the adherence of P-fimbriated Escherichia coli to uroepithelial cell surfaces by proanthocyanidin extracts from cranberries.  N Engl J Med. 1998;  339 1085-1086
• 11 Foo LY, Lu Y, Howell AB, Vorsa N. A-type proanthocyanidin trimers from cranberry that inhibit adherence of uropathogenic P-fimbriated Escherichia coli.  J Nat Prod. 2000;  63 1225-1228
• 12 Howell AB, Reed JD, Krueger CG. et al. . A-type cranberry proanthocyanidins and uropathogenic bacterial anti-adhesion activity.  Phytochemistry. 2005;  66 2281-2291
• 13 Foo LY, Lu Y, Howell AB, Vorsa N. The structure of cranberry proanthocyanidins which inhibit adherence of uropathogenic P-fimbriated Escherichia coli in vitro.  Phytochemistry. 2000;  54 173-181
• 14 Ahuja S, Kaack B, Roberts J. Loss of fimbrial adhesion with the addition of Vaccinium macrocarpon to the growth medium of P-fimbriated Escherichia coli.  J Urol. 1998;  159 559-562
• 15 Liu Y, Black MA, Caron L, Camesano TA. Role of cranberry juice on molecular-scale surface characteristics and adhesion behavior of Escherichia coli.  Biotechnol Bioeng. 2006;  93 297-305
• 16 Harmand MF, Blanquet P. The fate of total flavanolic oligomers (OFT) extracted from Vitis vinifera L. in the rat.  Eur J Drug Metab Pharmacokinet. 1978;  3 15-30
• 17 Howell AB, Leahy M, Kurowska E, Guthrie N. In vivo evidence that cranberry proanthocyanidins inhibit adherence of P-fimbriated E. coli bacteria to uroepithelial cells.  Fed Amer Soc Exp Biol J. 2001;  15 A284
• 18 Habash MB, van der Mei HC, Busscher HJ, Reid G. The effect of water, ascorbic acid, and cranberry derived supplementation on human urine and uropathogen adhesion to silicone rubber.  Can J Microbiol. 1999;  45 1189-1193
• 19 Di Martino P, Agniel R, David K. et al. . Reduction of Escherichia coli adherence to uroepithelial bladder cells after consumption of cranberry juice: a double-blind randomized placebo-controlled cross-over trial.  World J Urol. 2006;  24 21-27
• 20 Sun D, Abraham SN, Beachey EH. Influence of berberine sulfate on synthesis and expression of Pap fimbrial adhesin in uropathogenic Escherichia coli.  Antimicrob Agents Chemother. 1988;  32 1274-1277
• 21 Avorn J, Monane M, Gurwitz JH. et al. . Reduction of bacteriuria and pyuria after ingestion of cranberry and blueberry juices.  JAMA. 1994;  271 751-754
• 22 Kontiokari T, Sundqvist K, Nuutinen M. et al. . Randomised trial of cranberry-lingonberry juice und Lactobacillus GG drink for the prevention of urinary tract infections in women.  BMJ. 2001;  322 1571
• 23 Jepson RG, Mihaljevic L, Craig J. Cranberries for preventing urinary tract infections.  Cochrane Database Syst Rev. 2004; 
• 24 Stothers L. A randomized trial to evaluate effectiveness and cost effectiveness of naturopathic cranberry products as prophylaxis against urinary tract infection in women.  Can J Urol. 2002;  9 1558-1562
• 25 McMurdo ME, Bissett LY, Price RJ. et al. . Does ingestion of cranberry juice reduce symptomatic urinary tract infections in older people in hospital? A double-blind, placebo-controlled trial.  Age Ageing. 2005;  34 256-261
• 26 Beerepoot MA, Stobberingh EE, Geerlings SE. A study of non-antibiotic versus antibiotic prophylaxis for recurrent urinary-tract infections in women (the NAPRUTI study).  Ned Tijdschr Geneeskd. 2006;  150 574-575
• 27 Weiss EI, Lev-Dor R, Kashamn Y. et al. . Inhibiting interspecies coaggregation of plaque bacteria with a cranberry juice constituent.  J Am Dent Assoc. 1998;  129 1719-1723
• 28 Steinberg D, Feldman M, Ofek I, Weiss EI. Effect of a high-molecular-weight component of cranberry on constituents of dental biofilm.  J Antimicrob Chemother. 2004;  54 86-89
• 29 Steinberg D, Feldman M, Ofek I, Weiss EI. Cranberry high molecular weight constituents promote Streptococcus sobrinus desorption from artificial biofilm.  Int J Antimicrob Agents. 2005;  25 247-251
• 30 Weiss EI, Kozlovsky A, Steinberg D. et al. . A high molecular mass cranberry constituent reduces mutans streptococci level in saliva and inhibits in vitro adhesion to hydroxyapatite.  FEMS Microbiol Lett. 2004;  232 89-92
• 31 Bodet C, Chandad F, Grenier D. Anti-inflammatory activity of a high-molecular-weight cranberry fraction on macrophages stimulated by lipopolysaccharides from periodontopathogens.  J Dent Res. 2006;  85 235-239
• 32 Bodet C, Piche M, Chandad F, Grenier D. Inhibition of periodontopathogen-derived proteolytic enzymes by a high-molecular-weight fraction isolated from cranberry.  J Antimicrob Chemother. 2006;  57 685-690
• 33 Duarte S, Gregoire S, Singh AP. et al. . Inhibitory effects of cranberry polyphenols on formation and acidogenicity of Streptococcus mutans biofilms.  FEMS Microbiol Lett. 2006;  257 50-56
• 34 Yamanaka A, Kimizuka R, Kato T, Okuda K. Inhibitory effects of cranberry juice on attachment of oral streptococci and biofilm formation.  Oral Microbiol Immunol. 2004;  19 150-154
• 35 Burger O, Ofek I, Tabak M, Weiss EI. et al. . A high molecular mass constituent of cranberry juice inhibits Helicobacter pylori adhesion to human gastric mucus.  FEMS Immunol Med Microbiol. 2000;  29 295-301
• 36 Burger O, Weiss E, Sharon N, Tabak M. et al. . Inhibition of Helicobacter pylori adhesion to human gastric mucus by a high-molecular-weight constituent of cranberry juice.  Crit Rev Food Sci Nutr. 2002;  42 279-284
• 37 Chatterjee A, Yasmin T, Bagchi D, Stohs SJ. Inhibition of Helicobacter pylori in vitro by various berry extracts, with enhanced susceptibility to clarithromycin.  Mol Cell Biochem. 2004;  265 19-26
• 38 Shmuely H, Burger O, Neeman I. et al. . Susceptibility of Helicobacter pylori isolates to the antiadhesion activity of a high-molecular-weight constituent of cranberry.  Diagn Microbiol Infect Dis. 2004;  50 231-235
• 39 Zhang L, Ma J, Pan K, Go VL. et al. . Efficacy of cranberry juice on Helicobacter pylori infection: a double-blind, randomized placebo-controlled trial.  Helicobacter. 2005;  10 139-145
• 40 Wu X, Beecher GR, Holden JM. et al. . Lipophilic and hydrophilic antioxidant capacities of common foods in the United States.  J Agric Food Chem. 2004;  52 4026-4037
• 41 Sun J, Chu YF, Wu X, Liu RH. Antioxidant and anti-proliferative activities of common fruits.  J Agric Food Chem. 2002;  50 7449-7454
• 42 Chu YF, Liu RH. Cranberries inhibit LDL oxidation and induce LDL receptor expression in hepatocytes.  Life Sci. 2005;  77 1892-1901
• 43 Maatta-Riihinen KR, Kahkonen MP, Torronen AR, Heinonen IM. Catechins and procyanidins in berries of Vaccinium species and their antioxidant activity.  J Agric Food Chem. 2005;  53 8485-8491
• 44 Dartsch PC. Wissenschaftliches Gutachten im Auftrag der Fa. Töpfer GmbH 2006